Pharmaceuticals

Endo Health to buy Canada's Paladin Labs in $1.7-bn deal

06 Nov 2013

Mis-selling of drugs to cost J&J $2.2 bn in US settlement

05 Nov 2013

The cases, which date from the late 1990s through the early 2000s, involve alleged kickbacks to doctors and pharmacies to promote the antipsychotic drugs Risperdal and Invega, and heart drug Natrecor

Roche to pay $458 mn for rights to experimental antibiotic

05 Nov 2013

General Atlantic seeks $1.1 bn from sale of German laboratory-service provider Amedes Group

01 Nov 2013

China’s Fosun Pharma to sell two drugs to Switzerland’s Sellas Clinicals for $534 mn

24 Oct 2013

McKesson Corp buying German drugs distributor Celesio in $8.3-bn deal

24 Oct 2013

The acquisition of German drugs distributor Celesio by US health-care-services company McKesson Corp will  create the world’s largest pharmaceutical wholesaler

McKesson nears deal to buy German drugs distributor Celesio for €23 per share

24 Oct 2013

Wockhardt faces fresh strictures from UK drug regulator

23 Oct 2013

Reckitt Benckiser prepares to sell pharmaceuticals unit

23 Oct 2013

Actis invests Rs294 crore in Indore's Symbiotec Pharmalab

23 Oct 2013

Wockhardt recalls 5 drugs in UK after regulatory strictures

19 Oct 2013

Hungary, India sign pact to promote Ayurveda

18 Oct 2013

Zydus, Germany’s Pieris tie up to develop `Anticalin’ protein drugs

16 Oct 2013

Wockhardt gets another slap from UK drug regulator

14 Oct 2013

German nicotine-patch maker LTS Lohmann receives several bids

12 Oct 2013

KKR & Co to buy 30% in Gland Pharma for Rs920 crore: report

11 Oct 2013

Teva Pharmaceutical to cut 5,000 jobs, save $2 bn annually

11 Oct 2013

McKesson in advanced talks to buy German drugs distributor Celesio for $5.08 bn

08 Oct 2013

Indigenous vaccine for Japanese encephalitis launched

05 Oct 2013

The strain for this vaccine was isolated from the blood sample of an encephalitic patient admitted to government hospital in Karnataka

US biopharmaceutical company Ikaria Inc explores sale

04 Oct 2013

Avista Capital and Nordic Capital to buy Swiss generic drugmaker Acino for $439 mn

03 Oct 2013

Astex Pharma $886-mn merger with Japan’ Otsuka runs into shareholder trouble

03 Oct 2013

PE firms in race for J&J’s Ortho Clinical Diagnostics unit

01 Oct 2013

Private equity firms have tabled preliminary bids for Johnson & Johnson's Ortho Clinical Diagnostics unit, which could fetch the US healthcare major around $5 billion

GSK sells thrombosis drugs to Aspen for $1.13 billion

01 Oct 2013

The sale comes a month after London-based GSK agreed to sell its Lucozade and Ribena soft drink brands to Japan's Suntory Beverages for £1.35 billion

Supreme Court bans all drug trials for lack of monitoring mechanism

30 Sep 2013

The Supreme Court today banned all clinical trials for new drugs until a suitable monitoring mechanism for human trials is put in place